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ABSTRACT  
          Aconite (Aconitum napellus Linn.) commonly known as atis is a 
poisonous plant used extensively as antihypertensive, antipyretic, 
analgesic and antirheumatic. Ayurveda recommended the 
administration of aconite roots only after purification, i.e., boiling 
roots in cow’s urine (Gomutra). In the present study an attempt was 
made to compare the pro-arrhythmic and antihypertensive effects of 
powdered aconite root purified by shodhana process with that of 
unpurified form of aconite roots in order to provide scientific support 
of the claim in ayurvedic texts that purification of aconite root by 
shodhana process retains its antihypertensive activity and is devoid 
of pro-arrhythmic activity. Aconite root treatment in both forms 
(purified and unpurified) caused significant reduction in BP when 
compared with diseased control group (P<0.05). The unpurified 
aconite root group showed significant increase in heart rate, 
increase in QRS complex time and increase in QT interval, however 
these parameters were statistically insignificant in purified aconite 
root treated group. The PRA, SC and BUN levels was significantly 
decreased in aconite root treatment groups. The probable 
mechanism of antihypertensive activity of aconite root can be 
attributed to decrease in plasma renin activity, decrease in oxidative 
stress and increase in NO levels.  
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INTRODUCTION 
In Ayurveda, the ancient Indian system 
of medicine mainly deals with herbal and 
herbo- mineral formulations to cure the 
pathological symptoms as well as to maintain 
good health. Some of the most important 
herbal drugs are toxic in nature and hence 
Ayurveda has classified such drugs in the Visha- 
Upavisha Varga (poisonous and semi poisonous 
drugs) and mentions the Shodhana samskara 
(process of detoxification) for the same to 
reduce their toxicity and potentiate their 
medicinal properties (Medhava and Mishra, 
1999; Sharma, 2001).  According to ayurvedic 
texts shodhan vidhi is an important process 
which enhances the biological activity of a 
compound and reduces the toxicity at the same 
time. Before incorporating into formulations, 
guggul is processed using Shodhan vidhi 
involving different shodhan dravyas like gulvel, 
gomutra, triphala, dashmul (Kamble et al., 
2008). 
Raw aconite is an extremely lethal 
poison. Aconite's action is primarily cardiotoxic 
because of its effect on the inward sodium 
channels. It prolongs cardiac repolarization, 
and as a result, various arrhythmias-primarily 
ventricular-can occur. It is also neurotoxic 
(Rastogi et al., 2007; Singh et al., 1986; Chan, 
2009). However, the science of ayurveda looks 
upon it as a therapeutic entity. The ayurvedic 
science is full of pharmaceutical processing also 
called as ‘Samaskara’. shodhana treatment is 
also one type of samaskara. Raw aconite is 
always subjected to shodhana before being 
utilized in the ayurvedic formulations, and after 
shodhana treatment it is prescribed to combat 
various illnesses like fever, rheumatoid arthritis, 
sciatica, hypertension etc (Toshiaki et al., 2009; 
Rastogi, 2011). Some of the ayurvedic 
formulations containing aconite roots are 
Mahavisagarbha Taila, Rodhrasava, 
Lakasminarayana Rasa and Sudarsana Churna 
(Rastogi, 2011). 
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In the present study, aconite was purified 
by cow’s urine (shodhana) as described in 
ayurvedic text. In order to claim the 
detoxification effect  of shodhana process on 
aconite, the aconite roots was studied for its 
pro-arrhythmic and antihypertensive activity in 
both forms; i.e., raw aconite and shodhana 
treated aconite roots (Rastogi, 2011; Singh et al., 
1981; Singh et al., 1981). 
 
METHODOLOGY 
Materials 
The dried roots of Aconite (Aconitum 
napellus Linn.) was procured from Sanjivani 
Aaushdhalaya, Bhavnagar, Gujarat, India and 
was authenticated by Dr. P.S. Nagar, Head, 
Department of Botany, M.S. University of 
Baroda, Vadodara, Gujarat, India. A voucher 
specimen of the drug was kept for future 
reference (bot/bio/aut/09212/06). Roots of 
Aconite (Aconitium napellus Linn.) was purified 
by shodhana process using cow’s urine 
collected from local cow shed. Aconite roots 
(250g) were cut into small pieces and was 
placed into Dolayantra (an earthen pot of 10L 
capacity), which was filled with cow’s urine. 
Dolayantra was placed on fire and heated for 
3h daily for continuous three days. After three 
days the aconite roots were collected and 
washed thoroughly three times with cold water 
and dried under sun light. After drying roots 
were powdered (Thorat and Dahanukar, 1999; 
Sarkar and Prajapati, 2011). Olive oil 
suspensions of powdered aconite root of both 
purified and unpurified was prepared freshly 
before the administration of drug. 
Instruments: UV-Vis spectrophotometer 
(Specord, Analytic Jena, Germany), 
Homogeniser (Remi), High Speed Cooling 
Microcentrifuge (Remi C-24) and Student’s 
Physiograph (Biodevices) alongwith strain 
gauge coupler, pressure transducer, ECG 
coupler, ECG leads. 
Chemicals: AR grade ether, olive oil, 
thiobarbituric acid, Tris buffer, trichloroacetic 
acid, griess reagent, ethylenediamine tetraacetic 
acid and sodium nitrite were obtained from 
Qualikems Fine Chem. Pvt Ltd., Vadodara. 
 
Animals 
Adult wistar rats of either sex weighing 
between 250-300g were procured from animal 
house of Babaria Institute of Pharmacy, 
Vadodara. Approval of animal experimental 
protocol was taken by Institutional Animal 
Ethics Committee of Babaria Institute of 
Pharmacy, Vadodara (M.Ph.Sem-IV/11-12/04). 
Rats were housed in polypropylene cages with 
rice husk as the bedding material maintained 
under standardized condition (12h light/dark 
cycle , 24±1ºC, 35- 60% humidity) and provided 
with free access to commercial pellet diet (Mfg. 
by Nav Maharashtra Chakan Oil Mills Pvt. Ltd., 
Pune) and water ad libitum. Rats were randomly 
assigned to four groups with six animals in each 
group, viz., Normal Control (Olive oil 1ml, p.o.); 
Diseased control; Unpurified aconite root 
50mg/kg, p.o. and  Purified aconite root 
50mg/kg, p.o. The animals were treated with 
drug for 6days. 
 
Measurement of blood pressure and pro-
arrhythmic activity of powdered aconite 
roots against two kidney one clip 
renovascular hypertension model in rats 
(Goldbatt et al., 1934; Kotrly et al., 1984). 
Each day ECG in lead II were recorded 
on student physiograph (Biodevices). From ECG 
recording, the heart rate (beats/min), QRS 
complex time (in secs) and QT interval (in secs) 
was calculated. On 7th day, animals were 
anesthetized with ketamine (50mg/kg, i.p.) 
alongwith diazepam (5mg/kg).  A PVC-coated 
Dieffenbach clip was placed onto the left hilum 
of the kidney and fixed to the back muscles. A 
small cut was made on the left side of the 
abdomen. Through this incision left kidney is 
located and the renal artery was occluded for 3½ 
h. Carotid artery was cannulated with 50 PE tube. 
The trachea was cannulated to facilitate 
spontaneous respiration. To measure systolic and 
diastolic blood pressure, the cannula in the 
carotid artery was connected to a pressure 
transducer (student’s physiograph). After 
recording stable reduced blood pressure values, 
the renal arterial clip was removed. This leads to 
a rise in blood pressure as a consequence of 
elevated plasma renin level. Blood pressure was 
recorded & monitored continuously. Treatment 
groups were compared with disease control 
group. The purified aconite root treatments 
group was compared with unpurified aconite 
root treated groups. 
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At the end of experiment the blood 
sample of 2 ml was collected by retro-orbital 
puncture and allowed to clot for 10min at room 
temperature. Clots were centrifuged at 
2500rpm for 10min to separate the serum. 
Serum creatinine (Kaplan and Pesce et al., 
1996), Blood Urea Nitrogen (BUN) (Godkar 
and Godkar, 2009) and Plasma renin activity 
(PRA) (Wang et al., 1993) were measured by 
commercial available kits (Transasia Bio-
Medical Ltd). Animals were sacrificed and the 
left kidney was quickly removed, weighed & 
perfused immediately with ice cold hypertonic 
saline solution, weighed and homogenized in 
chilled Tris- buffer (10mM, pH 7.4) at a 
concentration of 10% (w/v). The homogenates 
were centrifuged at 10,000 rpm at 0°C for 
20min using Remi C-24 high speed cooling 
microcentrifuge. The clear supernatant was 
used for the assay of Nitrite (NO) (Lepoivre 
and Chenais, 1990), Malondialdehyde (MDA) 
(Ohkawa et al., 1979), Catalase (CAT) (Aebi, 
1984), Reduced Glutathione (GSH) (Moran e 
al., 1979) and Superoxide Dismutase (SOD) 
(Nandi and Chatterjee, 1988). 
Statistical Analysis of Results 
All values were expressed as Mean ± 
SEM. Statistical significance was tested between 
more than two groups using one-way ANOVA 
followed by Bonferoni’s post test by using a 
computer-based fitting program (Prism, Graph 
pad 5). Differences were considered to be 
statistically significant when P < 0.05. 
 
RESULTS AND DISCUSSION 
Effect of aconite on blood pressure 
Systolic and diastolic blood pressure 
were found to be statistically significant 
(P<0.05) increased in diseased control group as 
compared to normal control group that 
indicated hypertension in diseased control rats. 
Aconite root treatment (purified and 
unpurified) caused significant reduction in 
systolic & diastolic blood pressure when 
compared with diseased control group 
(P<0.05). However, when unpurified aconite 
root treated group was compared with that of 
unpurified aconite treatment group; no 
statistically significant change in systolic and 
diastolic blood pressure was observed (Table I). 
Table I. Effect of aconite on blood pressure 
 
Treatment 
Systolic blood 
pressure (mmHg) 
Diastolic blood 
pressure (mmHg) 
Normal control 123.0 ± 3.7 66.7 ± 2.5 
Disease control (Sham operated) 156.2 ± 4.2$ 97.7 ± 2.0$ 
Aconite unpurified  (50mg/kg, p.o) 140.0 ± 2.6@ 80.2 ± 1.5@ 
Aconite purified (50mg/kg, p.o) 137.5 ± 1.8@ 76.0 ± 1.6@ 
 
Values are Mean ± S.E.M. (n=6). 
$ P < 0.05 when compared to normal control group 
@ P < 0.05 when compared to diseased control group 
ANOVA one way followed by Bonferoni’s post test 
 
Table II. Effect of aconite on ECG 
 
Treatment 
Heart rate 
(beats/min) 
QRS complex 
(Sec) 
Q-T interval 
(Sec) 
Normal control 359.8 ± 18.9 0.023 ± 0.001 0.068 ± 0.020 
Aconite unpurified (50mg/kg, p.o) 480.0 ± 13.8@ 0.042 ± 0.007@ 0.084± 0.001@ 
Aconite purified (50mg/kg, p.o) 375.7 ± 17.9* 0.029± 0.003* 0.067 ± 0.003* 
 
Values are Mean ± S.E.M. (n= 6). 
@ P < 0.05 when compared to normal control group 
* P < 0.05 when compared to unpurified aconite treated group.  
ANOVA one way followed by Bonferoni’s post test 
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This particular observation suggests that the 
purification of aconite by shodhana process 
retains the antihypertensive activity. 
 
Effect of aconite on ECG 
When Aconite drug treatment group 
(both purified and unpurified) were compared 
with normal control group, statistical significant 
(P<0.05) increase in heart rate, increase in QRS 
complex time and increase in QT interval was 
observed only in unpurified aconite root treated 
group. The changes in heart rate, QRS and QT 
time in purified aconite root treated group was 
not found to be significant (Table II). This 
indicates that shodhana purified aconite root is 
devoid of the pro-arrhythmic activity and hence 
a strong evidence of the ayurvedic claim that 
shodhana process of aconite using cow’s urine 
diminishes the pro-arrhythmic effect. 
Unpurified Aconite contains aconitine 
which is highly toxic to the heart. Aconitine 
blocks HERG and Kv1.5 potassium channels in 
the open state. Blockage of potassium channels, 
particular the HERG channel may be one of 
the important mechanisms of how aconitine 
induces arrhythmias. Aconite is purified by 
shodhana using cow’s urine. After sodhana 
process the aconitine converts into aconine, 16-
epidesbenzoyl pyroaconine, and the major 
hydrolysis product is benzoylaconine. Thus the 
Aconitine concentration is reduced after 
purification (Li and Tu, 2010). 
 
Effect of aconite on plasma renin 
activity (PRA), serum creatinine, blood 
urea nitrogen 
In order to elucidate the probable 
mechanism of the antihypertensive activity of 
the aconite root, various markers for the 
antihypertensive activity is also determined. 
The plasma renin activity, serum creatinine and 
blood urea nitrogen was significantly decreased 
in aconite root treatment groups when 
compared with diseased control group 
(P<0.05). However, no significant change was 
observed between aconite treatment groups for 
these serum parameters (Table III). The renin-
angiotensin system (RAS) plays a dominant role 
in the regulation of the blood pressure. 
Angiotensin converting enzyme (ACE) is the 
most important regulatory site of RAS. The 
importance of ACE inhibitors in the chronic 
treatment of various cardiovascular diseases 
such as hypertension, congestive heart failure, 
myocardial infarction, diabetic nephropathy, or 
renal dysfunction is now well established. 
The present study showed an anti-
hypertensive effect of Unpurified and Purified 
sample of Aconite in two kidney one clip 
(2K1C) renovascular hypertension. The 2K1C 
model is characterized by an increase in blood 
pressure immediately after clipping, which 
parallels the release of active renin 
concentration. The plasma and renal renin 
levels  were  found  to increase in both the early 
and chronic phase of 2K1C hypertensive rats.  
Table III. Effect of aconite root treatment on Plasma Rennin Activity (PRA), serum creatinine, 
Blood Urea Nitrogen(BUN) and Nitric Oxide(NO). 
 
Treatment 
Plasma Renin activity 
(ng/mL/hr) 
Serum creatinine 
mg/dL 
BUN 
mg/dL 
Normal Control 5.50 ± 0.67 1.13 ± 0.14 31.00 ± 3.12 
Disease Control 14.33 ± 1.23$ 2.70 ± 0.24$ 52.17 ± 3.40$ 
Aconite unpurified 
(50mg/kg, p.o) 
9.83 ± 1.26@ 1.73 ± 0.15@ 38.50 ± 1.73@ 
Aconite purified 
(50mg/kg, p.o) 
9.33 ± 0.88@ 1.63 ± 0.13@ 38.33 ± 1.17@ 
 
Values are Mean ± S.E.M. (n=6). 
$ P < 0.05 when compared to normal control group 
@ P < 0.05 when compared to diseased control group 
ANOVA one way followed by Bonferoni’s post test 
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The ACE is the most important regulatory site 
of RAS. The ACE plays an important role in 
the regulation of blood pressure and diuresis. It 
catalyzes the hydrolysis of Angiotensin-I to 
Angiotensin-II, which is a powerful vaso-
constrictor. Angiotensin-II also increases the 
synthesis and release of aldosterone, which 
cause sodium and water retention. Aconite 
powder blocked the increase of blood pressure 
in 2K1C hypertensive rats. These results 
suggest that Aconite powder has an 
antihypertensive effect via the inhibition of 
ACE, an essential enzyme of RAS. The 
important findings in this study were that 
Unpurified and purified sample of Aconite 
significantly    decrease    renin   level  in animal  
model of hypertension. In this 2K1C model 
due to occlusion of one kidney the GFR was 
decrease, which cause rise in the level of serum 
creatinine and BUN in hypertensive model. 
Both unpurified and purified sample of aconite 
root caused significant reduction in serum 
creatinine and BUN in hypertensive model and 
thus also helps in reduction of blood pressure.  
The present study concluded that there 
was not much more difference in the capacity 
of reduction of renin-levels, serum creatinine 
level and BUN by purified and unpurified 
sample of aconite in hypertensive model, which 
suggest that antihypertensive effect was not 
affected due to shodhana process. 
Effect of aconite root treatment on 
oxidative stress markers in kidney 
tissue. 
Oxidative stress markers catalase, 
superoxide dismutase, malondialdehyde, 
glutathione levels were measured in kidney 
tissue homogenate supernatant. The nitric 
oxide levels are also measured as it is involved 
in vasodilative effect of a drug.  
Renal artery occlusion cause oxidative 
stress that is responsible for kidney damage and 
hence hypertension therefore the catalase, 
glutathione, superoxide dismutase levels are 
significantly decreased in diseased control 
group in comparison to normal control group. 
MDA levels are significantly increased 
indicating lipid peroxidation in kidney tissue in 
diseased control group. 
It can be seen from the table that aconite 
root treatment (purified or unpurified form) 
group there is a significant increase in catalase, 
glutathione, superoxide dismutase and nitric 
oxide levels and decrease in MDA levels in 
kidney tissue when compared with diseased 
control group (Table IV). 
When compared between aconite root 
treatment groups significant increase was found 
only in NO levels. It suggests that increase in 
NO levels may be responsible for protection 
against pro-arrhythmic activity. 
Assessment of antioxidant activities and 
lipid peroxidation by products in hypertensive 
Table IV. Effect of aconite on oxidative stress markers in kidney tissue. 
 
Treatment 
CAT 
µM of H2O2  
consumed/ g  
of tissue 
GSH 
µg/g of 
tissue 
SOD 
Units/g of 
tissue 
MDA 
nM/g of 
tissue 
NO 
µM/g of 
tissue 
Normal Control 321.7 ± 6.2 148.2 ± 10.1 104.2 ± 6.8 73.00 ± 3.9 8.95 ± 1.29 
Disease Control 199.2 ± 11.6$ 79.29 ± 7.4$ 45.83 ± 6.5$ 125.8 ± 5.8$ 1.95 ± 0.27$ 
Aconite unpurified 
(50mg/kg, p.o) 
265.8 ± 4.7@ 118.3 ± 5.4@ 76.33 ± 5.7@ 96.67 ± 5.7@ 4.05 ± 0.35@ 
Aconite purified 
(50mg/kg, p.o) 
270.8 ± 4.7@ 124.3 ± 5.1@ 80.83 ± 4.7@ 93.33 ± 4.4@ 5.17 ± 0.30@* 
 
Values are Mean ± S.E.M. (n=6). 
$ P < 0.05 when compared to normal control group 
@ P < 0.05 when compared to diseased control group 
* P < 0.05 when compared to unpurified aconite treated group.  
CAT: catalase; GSH: glutathione; SOD: superoxide dismutase; NO: nitric oxide 
ANOVA one way followed by Bonferoni’s post test      
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subjects indicate an excessive amount of ROS 
& a reduction of antioxidant mechanism 
activity in both blood as well as in several other 
cellular systems. It is known that reactive 
oxygen species (ROS) contribute to the 
pathogenesis of numerous cardiovascular 
diseases including hypertension, atherosclerosis 
cardiac hypertrophy and heart failure. 
NAD(P)H oxidative being the predominant 
source of ROS (McIutyre and Bohr, 1999). 
SOD, CAT, and GSH are the three primary 
antioxidant enzymes among the endogenous 
systems for removal of reactive oxygen species 
(Bukan et al., 2003). 
Reduction in oxidative stress represents 
a potential mechanism by which NO prevents 
arrhythmia. Recently NO mediated reductions 
in O2- have been implicated in preconditioning 
mediated protection from arrhythmia in dogs. 
It was found that reductions in arrhythmia were 
associated with both increased NO production 
and decreased oxidative stress (Dylan and 
Qingping, 2011). 
 
CONCLUSION 
The unpurified aconite root group 
showed significant increase in heart rate, 
increase in QRS complex time and increase in 
QT interval, however these parameters were 
statistically insignificant in purified aconite root 
treated group. The PRA, SC and BUN levels 
was significantly decreased in aconite root 
treatment groups. The probable mechanism of 
antihypertensive activity of aconite root can be 
attributed to decrease in plasma renin activity, 
decrease in oxidative stress and increase in NO 
levels.  
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